NCT03763643 · Interventional trial
PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
Overall registry status Completed
Early Phase 1
Conditions Focal Segmental Glomerulosclerosis
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory